Condition: Renal Pelvis and Ureter Urothelial Carcinoma

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07630155

Sponsor: University of Michigan Rogel Cancer Center

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged ≥ 18 year. Both sexes are included to reflect the patient population with upper tract urothelial carcinoma (UTUC) already being followed at the University of Michigan and allow exploration of potential differences in tolerability of awake ureteroscopy based on sex
• History of endoscopically managed UTUC at any time, or a suspected diagnosis of UTUC based on pre-procedure imaging, and is already planned for office-based ureteroscopic assessment
• Ability and willingness to complete and adhere to survey questions and responses throughout study duration

Exclusion Criteria:

• Known ureteral strictures
• Active urinary tract infection
• Need for general anesthesia due to patient or procedural factors
• History of inability to tolerate ureteroscopy under local anesthetic
• Anticipated need for laser ablation during the surveillance procedure
• Pregnancy

View trial on ClinicalTrials.gov